Notice of Changes to Funding Opportunities

• Rescinding NOT-HG-20-041 NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July and Clarifying the Late Application Receipt Dates of NHGRI-Specific FOAs (NOT-HG-20-042)
  (NOT-HG-20-042)
  National Human Genome Research Institute
  

• Notice of Change in Application Due Date for RFA-HL-20-029 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional)"
  (NOT-HL-20-794)
  National Heart, Lung, and Blood Institute
  

Funding Opportunities

• National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)
  (PAR-20-213)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)
  (PAR-20-221)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)
  (PAR-20-223)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): June 24, 2020; June 24, 2021; June 24, 2022
  
  

• Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional)
  (PAR-20-224)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below
  
  

• Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
  (PAR-20-225)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 19, 2020, October 19, 2021, October 19, 2022 by 5:00 PM local time of applicant organization.